Michael Steinmetz

Filings by Michael Steinmetz span 3 companies, the busiest being Acorda Therapeutics Inc, Omrix Biopharmaceuticals, Inc. and Critical Therapeutics Inc. Over a trading history stretching from 15 February 2006 to 13 February 2007, the count stands at 11 filings.

Every open-market trade on record is a purchase: 1 purchase worth €841k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The latest filing, published on 15 February 2007, reports a transaction in Critical Therapeutics Inc. The last purchase on record was published on 17 February 2006, which is 7,570 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.